Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy is a research paper published in Journal of Clinical Investigation (2011). On theSindex it has a DataRank of 12.2. It has been cited 419 times, with 200 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.906
From this paper's citation signal
Citation Network Contribution
11.3
From 200 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 200 citers.
NCI NIH HHS
Grant: 5-R01-CA-105118-04
NCI NIH HHS
Grant: R01 CA105118
National Institutes of Health
Grant: 5R01CA105118-04
PI3K opposes p27 and G1 arrest by TGF-B in human cancer
FWCI
17.14
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals